Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

November 2019 Issue of The Cannabis Scientist

Time to abandon our grow rooms? To find out, we speak with leading figures to explore the rise of synthetic biology in cannabinoid production. Our In My View section has a focus on the legislative hurdles hindering research either side of the Atlantic. Mark Barnes reflects on the state of medical cannabis and government policy in the UK in this month’s Sitting Down With. Evolving policy, however, presents evolving challenges, such as the need for roadside THC testing and cannabis education – efforts detailed in our upfront section.

Register to download

Register here to download any issue of The Cannabis Scientist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Research & Development Medical research

Powering Up Cannabis Clinical Trials

| Charlotte Barker

The message is clear: we need more evidence. But are randomized, controlled trials the answer?

Research & Development Neurology & psychology

Balancing Act

| Matthew Hallam

Does CBD really counteract the neuropsychiatric risks of THC?

Testing & Processing Cannabinoid analysis

Carbon Nanotubes for Cannabis Control

| Jonathan James

Freeing the roads of THC-intoxicated drivers, one breathalyzer test at a time

Business & Profession Education

Cannabis 101

| Jonathan James

Training the cannabis scientists of tomorrow has never been more important

Research & Development Medical research

Jump into the Patient Pool: The Data's Lovely

| Jonathan James

How are Canadians using medical cannabis?

Business & Profession Legislation & policy

The View from Texas

| Kevin Schug

Restrictive legislation won’t prevent efforts to progress cannabis research

Business & Profession Legislation & policy

Vape Flavor Regulation: a Sour Taste in the Mouth?

| Brad Douglass

Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly

Research & Development Tools & technology

The Cannabinoid Factories of the Future

| Matthew Hallam

Could synthetic biology facilitate a microbial revolution... and do away with grow rooms for good?

Business & Profession Legislation & policy

Cannabis in the UK: From Policy to Practice

Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.

Other issues of 2019